The no-reflow phenomenon: A light at the end of the tunnel?

Catheterization and Cardiovascular Interventions

Volumn 51, Issue 4, 2000, Pages 400-401

  Lotan, Chaim ^a   Shaohong, Dong ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY BLOOD FLOW; ARTIFICIAL EMBOLISM; EDITORIAL; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MICROCIRCULATION; PROGNOSIS; REPERFUSION; THROMBOSIS; UNSTABLE ANGINA PECTORIS; VASOCONSTRICTION;

ADENOSINE; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; HUMANS; POSTOPERATIVE COMPLICATIONS; VASODILATOR AGENTS;

EID: 0033667614     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-726X(200012)51:4<400::AID-CCD5>3.0.CO;2-V     Document Type: Editorial

References (17)

1. The no-reflow phenomenon after temporary coronary occlusion in the dog
2. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions
3. Features and outcome of no-reflow after percutaneous coronary intervention
4. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention
5. No reflow revisited
6. Rapid reversal of no-reflow using abciximab after coronary device intervention
7. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty
8. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization
9. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion
10. Ischemia and activated neutrophils alter coronary microvascular but not epicardial coronary artery reactivity
11. Treatment of no-reflow in degenerated saphenous vein graft interventions: Comparison of intracoronary verapamil and nitroglycerine
12. Adenosine and its cardiovascular effects
13. Reversal of no-reflow during vein graft stenting using high velocity boluses of intracoronary adenosine
14. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon
15. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon
16. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system
17. Clinical safety and efficacy of the percusurge guardwire in the saphenous vein graft angioplasty free of emboli (SAFE) study